Dr Bartlomiej Tomasz Leyko, MD | |
300 W Clarendon Ave, Ste 120, Phoenix, AZ 85013-3421 | |
(602) 277-3337 | |
(602) 277-3330 |
Full Name | Dr Bartlomiej Tomasz Leyko |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 25 Years |
Location | 300 W Clarendon Ave, Phoenix, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538124946 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 32617 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Banner Thunderbird Medical Center | Glendale, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Allergy Asthma Clinic Ltd | 7517942493 | 3 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced its participation in the UBS Global Life Sciences Conference to be held on September 21-23, 2009 in New York City.
A new study has found that many male cancer survivors who develop testosterone deficiency after receiving chemotherapy or radiation therapy have an impaired quality of life and reduced energy levels. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that young male cancer survivors with testosterone deficiency may benefit from testosterone replacement therapy.
The Female Health Company (FHCO), which manufactures and markets the FC2 Female Condom®, today reported its operating results for the first quarter of FY2010.
Teva Pharmaceutical Industries Ltd. announced today that additional data from the Phase III clinical program for QNASL- (beclomethasone dipropionate) Nasal Aerosol will be presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, CA on November 8-13, 2012.
› Verified 9 days ago
Entity Name | Allergy Asthma Clinic Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609834373 PECOS PAC ID: 7517942493 Enrollment ID: O20040623001278 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced its participation in the UBS Global Life Sciences Conference to be held on September 21-23, 2009 in New York City.
A new study has found that many male cancer survivors who develop testosterone deficiency after receiving chemotherapy or radiation therapy have an impaired quality of life and reduced energy levels. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that young male cancer survivors with testosterone deficiency may benefit from testosterone replacement therapy.
The Female Health Company (FHCO), which manufactures and markets the FC2 Female Condom®, today reported its operating results for the first quarter of FY2010.
Teva Pharmaceutical Industries Ltd. announced today that additional data from the Phase III clinical program for QNASL- (beclomethasone dipropionate) Nasal Aerosol will be presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, CA on November 8-13, 2012.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Bartlomiej Tomasz Leyko, MD 300 W Clarendon Ave, Ste 120, Phoenix, AZ 85013-3421 Ph: (602) 277-3337 | Dr Bartlomiej Tomasz Leyko, MD 300 W Clarendon Ave, Ste 120, Phoenix, AZ 85013-3421 Ph: (602) 277-3337 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced its participation in the UBS Global Life Sciences Conference to be held on September 21-23, 2009 in New York City.
A new study has found that many male cancer survivors who develop testosterone deficiency after receiving chemotherapy or radiation therapy have an impaired quality of life and reduced energy levels. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that young male cancer survivors with testosterone deficiency may benefit from testosterone replacement therapy.
The Female Health Company (FHCO), which manufactures and markets the FC2 Female Condom®, today reported its operating results for the first quarter of FY2010.
Teva Pharmaceutical Industries Ltd. announced today that additional data from the Phase III clinical program for QNASL- (beclomethasone dipropionate) Nasal Aerosol will be presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, CA on November 8-13, 2012.
› Verified 9 days ago
Fadia K Habib-khazen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4901 N 44th St Ste 103, Phoenix, AZ 85018 Phone: 602-954-0405 Fax: 602-954-0485 | |
Mark Samuel Schubert, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 W Clarendon Ave, Ste 120, Phoenix, AZ 85013 Phone: 602-277-3337 Fax: 602-277-3330 | |
Praveena R Kothur, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4901 N 44th St Ste 103, Phoenix, AZ 85018 Phone: 602-954-0405 Fax: 602-954-0485 | |
Dr. Christopher E. Couch, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 300 W Clarendon Ave, Suite 120, Phoenix, AZ 85013 Phone: 602-277-3337 Fax: 602-277-3330 | |
Dr. Allan M Wachter, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 12020 S Warner Elliot Loop, Suite 124, Phoenix, AZ 85044 Phone: 480-785-8000 Fax: 480-705-8129 | |
Dr. Stephen N Finberg, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6970 E Chauncey Ln Ste 100, Phoenix, AZ 85054 Phone: 602-788-7211 Fax: 602-788-1890 | |
Thomas Mirzai, D.O. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3815 E Bell Rd, 4400, Phoenix, AZ 85032 Phone: 602-788-7211 Fax: 602-788-1890 |